Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
EMBO J
1997 Feb 03;163:611-24. doi: 10.1093/emboj/16.3.611.
Show Gene links
Show Anatomy links
Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR.
Benkirane M
,
Neuveut C
,
Chun RF
,
Smith SM
,
Samuel CE
,
Gatignol A
,
Jeang KT
.
???displayArticle.abstract???
TAR RNA binding protein (TRBP) belongs to an RNA binding protein family that includes the double-stranded RNA-activated protein kinase (PKR), Drosophila Staufen and Xenopus xlrbpa. One member of this family, PKR, is a serine/threonine kinase which has anti-viral and anti-proliferative effects. In this study we show that TRBP is a cellular down-regulator of PKR function. Assaying expression from an infectious HIV-1 molecular clone, we found that PKR inhibited viral protein synthesis and that over-expression of TRBP effectively countered this inhibition. In intracellular and in cell-free assays we show that TRBP directly inhibits PKR autophosphorylation through an RNA binding-independent pathway. Biologically, TRBP serves a growth-promoting role; cells that overexpress TRBP exhibit transformed phenotypes. Our results demonstrate the oncogenic potential of TRBP and are consistent with the notion that intracellular PKR function contributes physiologically towards regulating cellular proliferation.
Adachi,
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
1986, Pubmed
Adachi,
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
1986,
Pubmed
Agy,
Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
1995,
Pubmed
Barber,
Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation.
1995,
Pubmed
Blair,
Expression of TAR RNA-Binding Protein in Baculovirus and Co-Immunoprecipitation with Insect Cell Protein Kinase.
1995,
Pubmed
Chong,
Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2.
1992,
Pubmed
Coccia,
Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment.
1994,
Pubmed
Cosentino,
Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo.
1995,
Pubmed
Davies,
The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2.
1992,
Pubmed
Der,
Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity.
1995,
Pubmed
Dever,
Mammalian eukaryotic initiation factor 2 alpha kinases functionally substitute for GCN2 protein kinase in the GCN4 translational control mechanism of yeast.
1993,
Pubmed
Donzé,
Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells.
1995,
Pubmed
Dubois,
Modified subcellular localization of interferon-induced p68 kinase during encephalomyocarditis virus infection.
1990,
Pubmed
Edery,
Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism.
1989,
Pubmed
Edlin,
In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response.
1992,
Pubmed
Francis,
Interferons in the persistence, pathogenesis, and treatment of HIV infection.
1992,
Pubmed
Gatignol,
Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen.
1993,
Pubmed
Hovanessian,
The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK.
1989,
Pubmed
Hovanessian,
Rapid decrease in the levels of the double-stranded RNA-dependent protein kinase during virus infections.
1987,
Pubmed
Imani,
Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein.
1988,
Pubmed
Jeang,
In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.
1993,
Pubmed
Judware,
Mechanism of action of a cellular inhibitor of the dsRNA-dependent protein kinase from 3T3-F442A cells.
1992,
Pubmed
Katze,
The war against the interferon-induced dsRNA-activated protein kinase: can viruses win?
1992,
Pubmed
Kaufman,
Control of gene expression at the level of translation initiation.
1994,
Pubmed
Kitajewski,
Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase.
1986,
Pubmed
Koromilas,
Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase.
1992,
Pubmed
Kozak,
Genetic mapping in human and mouse of the locus encoding TRBP, a protein that binds the TAR region of the human immunodeficiency virus (HIV-1).
1995,
Pubmed
Kumar,
Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B.
1994,
Pubmed
Lee,
The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis.
1994,
Pubmed
Lee,
Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase.
1992,
Pubmed
Lee,
The interferon-induced double-stranded RNA-activated human p68 protein kinase potently inhibits protein synthesis in cultured cells.
1993,
Pubmed
Lengyel,
Tumor-suppressor genes: news about the interferon connection.
1993,
Pubmed
Maitra,
HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes.
1994,
Pubmed
McCormack,
Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity.
1994,
Pubmed
McCormack,
Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase.
1992,
Pubmed
McMillan,
HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR.
1995,
Pubmed
Meurs,
Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth.
1992,
Pubmed
Meurs,
Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon.
1990,
Pubmed
Mundschau,
Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2 alpha-kinase activation.
1992,
Pubmed
Park,
TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR.
1994,
Pubmed
Patel,
The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo.
1995,
Pubmed
Petryshyn,
Growth-related expression of a double-stranded RNA-dependent protein kinase in 3T3 cells.
1984,
Pubmed
Pitha,
Multiple effects of interferon on the replication of human immunodeficiency virus type 1.
1994,
Pubmed
Ramaiah,
Expression of mutant eukaryotic initiation factor 2 alpha subunit (eIF-2 alpha) reduces inhibition of guanine nucleotide exchange activity of eIF-2B mediated by eIF-2 alpha phosphorylation.
1994,
Pubmed
Roy,
The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence of RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase.
1991,
Pubmed
Sonenberg,
Measures and countermeasures in the modulation of initiation factor activities by viruses.
1990,
Pubmed
Thomis,
Mechanism of interferon action: autoregulation of RNA-dependent P1/eIF-2 alpha protein kinase (PKR) expression in transfected mammalian cells.
1992,
Pubmed
Whitaker-Dowling,
Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase.
1984,
Pubmed
Williams,
Transcriptional regulation of interferon-stimulated genes.
1991,
Pubmed
Yang,
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.
1995,
Pubmed
